HalozymeTherapeutics HALO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSIHalozyme Therapeutics HALO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange
operates under Health Care sector & deals in Biotechnology Biological Products No Diagnostic Substances
Daily price and charts and targets HalozymeTherapeutics Strong Daily Stock price targets for HalozymeTherapeutics HALO are 70.09 and 72.35 | Daily Target 1 | 68.4 | | Daily Target 2 | 69.51 | | Daily Target 3 | 70.656666666667 | | Daily Target 4 | 71.77 | | Daily Target 5 | 72.92 |
Daily price and volume Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Wed 12 November 2025 |
70.63 (0.71%) |
70.40 |
69.54 - 71.80 |
0.6949 times |
Tue 11 November 2025 |
70.13 (3.12%) |
67.96 |
67.39 - 70.23 |
0.6649 times |
Mon 10 November 2025 |
68.01 (-0.34%) |
68.48 |
67.98 - 69.39 |
0.8851 times |
Fri 07 November 2025 |
68.24 (-0.22%) |
69.02 |
67.52 - 70.00 |
4.1644 times |
Thu 06 November 2025 |
68.39 (0.16%) |
68.30 |
67.39 - 70.50 |
0.8317 times |
Wed 05 November 2025 |
68.28 (0.34%) |
68.58 |
67.80 - 70.49 |
0.2505 times |
Tue 04 November 2025 |
68.05 (4.39%) |
67.64 |
65.00 - 69.93 |
0.8569 times |
Fri 31 October 2025 |
65.19 (0%) |
64.10 |
63.84 - 65.49 |
0.5053 times |
Fri 31 October 2025 |
65.19 (0.87%) |
64.10 |
63.84 - 65.49 |
0.5053 times |
Thu 30 October 2025 |
64.63 (-0.97%) |
65.51 |
63.95 - 66.24 |
0.641 times |
Wed 29 October 2025 |
65.26 (-0.21%) |
65.74 |
64.95 - 66.97 |
0.5368 times |
Weekly price and charts HalozymeTherapeutics Strong weekly Stock price targets for HalozymeTherapeutics HALO are 69.01 and 73.42 | Weekly Target 1 | 65.53 | | Weekly Target 2 | 68.08 | | Weekly Target 3 | 69.94 | | Weekly Target 4 | 72.49 | | Weekly Target 5 | 74.35 |
Weekly price and volumes for Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Wed 12 November 2025 |
70.63 (3.5%) |
68.48 |
67.39 - 71.80 |
0.678 times |
Fri 07 November 2025 |
68.24 (4.68%) |
67.64 |
65.00 - 70.50 |
1.8434 times |
Fri 31 October 2025 |
65.19 (0%) |
64.10 |
63.84 - 65.49 |
0.1526 times |
Fri 31 October 2025 |
65.19 (-1.45%) |
66.80 |
63.84 - 66.99 |
0.7567 times |
Fri 24 October 2025 |
66.15 (-1.31%) |
67.07 |
65.14 - 67.36 |
0.7145 times |
Fri 17 October 2025 |
67.03 (4.57%) |
64.26 |
64.10 - 68.00 |
1.1114 times |
Fri 10 October 2025 |
64.10 (-7.07%) |
69.15 |
63.78 - 69.46 |
1.0084 times |
Fri 03 October 2025 |
68.98 (-6.47%) |
73.75 |
68.04 - 76.30 |
1.3547 times |
Fri 26 September 2025 |
73.75 (-5.22%) |
78.12 |
73.18 - 79.50 |
1.1069 times |
Fri 19 September 2025 |
77.81 (1.18%) |
77.18 |
75.19 - 77.95 |
1.2734 times |
Fri 12 September 2025 |
76.90 (2.63%) |
74.60 |
74.22 - 77.60 |
0.8327 times |
Monthly price and charts HalozymeTherapeutics Strong monthly Stock price targets for HalozymeTherapeutics HALO are 67.82 and 74.62 | Monthly Target 1 | 62.34 | | Monthly Target 2 | 66.49 | | Monthly Target 3 | 69.143333333333 | | Monthly Target 4 | 73.29 | | Monthly Target 5 | 75.94 |
Monthly price and volumes Halozyme Therapeutics
| Date |
Closing |
Open |
Range |
Volume |
Wed 12 November 2025 |
70.63 (8.34%) |
67.64 |
65.00 - 71.80 |
0.5847 times |
Fri 31 October 2025 |
65.19 (-11.11%) |
75.20 |
63.78 - 76.30 |
1.0897 times |
Tue 30 September 2025 |
73.34 (0.26%) |
71.78 |
71.50 - 79.50 |
1.0759 times |
Fri 29 August 2025 |
73.15 (21.98%) |
59.82 |
58.53 - 74.07 |
1.1585 times |
Thu 31 July 2025 |
59.97 (15.28%) |
51.78 |
51.78 - 61.75 |
0.7736 times |
Mon 30 June 2025 |
52.02 (-7.22%) |
55.69 |
51.06 - 56.32 |
1.4515 times |
Fri 30 May 2025 |
56.07 (-8.71%) |
61.00 |
47.50 - 70.51 |
1.7755 times |
Wed 30 April 2025 |
61.42 (-3.75%) |
64.06 |
55.71 - 64.17 |
0.7528 times |
Mon 31 March 2025 |
63.81 (7.88%) |
59.14 |
56.90 - 66.00 |
0.7789 times |
Fri 28 February 2025 |
59.15 (4.43%) |
55.12 |
54.96 - 60.67 |
0.5588 times |
Fri 31 January 2025 |
56.64 (18.47%) |
48.23 |
47.52 - 57.46 |
0.7911 times |
DMA SMA EMA moving averages of Halozyme Therapeutics HALO
DMA (daily moving average) of Halozyme Therapeutics HALO
| DMA period | DMA value | | 5 day DMA | 69.08 | | 12 day DMA | 67.28 | | 20 day DMA | 66.97 | | 35 day DMA | 67.86 | | 50 day DMA | 70.39 | | 100 day DMA | 66.08 | | 150 day DMA | 63.03 | | 200 day DMA | 62.21 | EMA (exponential moving average) of Halozyme Therapeutics HALO
| EMA period | EMA current | EMA prev | EMA prev2 | | 5 day EMA | 69.25 | 68.56 | 67.78 | | 12 day EMA | 68.08 | 67.62 | 67.16 | | 20 day EMA | 67.87 | 67.58 | 67.31 | | 35 day EMA | 69.06 | 68.97 | 68.9 | | 50 day EMA | 70.51 | 70.51 | 70.53 |
SMA (simple moving average) of Halozyme Therapeutics HALO
| SMA period | SMA current | SMA prev | SMA prev2 | | 5 day SMA | 69.08 | 68.61 | 68.19 | | 12 day SMA | 67.28 | 66.89 | 66.55 | | 20 day SMA | 66.97 | 66.75 | 66.58 | | 35 day SMA | 67.86 | 68 | 68.21 | | 50 day SMA | 70.39 | 70.47 | 70.54 | | 100 day SMA | 66.08 | 65.9 | 65.73 | | 150 day SMA | 63.03 | 62.96 | 62.87 | | 200 day SMA | 62.21 | 62.13 | 62.06 |
|
|
